ES2124229T3 - Factor anti-inflamatorio, metodo de aislamiento y uso. - Google Patents

Factor anti-inflamatorio, metodo de aislamiento y uso.

Info

Publication number
ES2124229T3
ES2124229T3 ES91915601T ES91915601T ES2124229T3 ES 2124229 T3 ES2124229 T3 ES 2124229T3 ES 91915601 T ES91915601 T ES 91915601T ES 91915601 T ES91915601 T ES 91915601T ES 2124229 T3 ES2124229 T3 ES 2124229T3
Authority
ES
Spain
Prior art keywords
factor
inflammatory factor
milk
animal
insulation method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91915601T
Other languages
English (en)
Inventor
Lee R Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stolle Research and Development Corp
Original Assignee
Stolle Research and Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Research and Development Corp filed Critical Stolle Research and Development Corp
Application granted granted Critical
Publication of ES2124229T3 publication Critical patent/ES2124229T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A UN FACTOR ANTIINFLAMATORIO SUBSTANCIALMENTE PURO AISLADO A PARTIR DE LA LECHE RECOGIDA DE UN ANIMAL PRODUCTOR DE LECHE, A LA PURIFICACION, IDENTIFICACION Y CARACTERIZACION DE DICHO FACTOR, Y A UN METODO PARA TRATAR LAS INFLAMACIONES EN ANIMALES QUE COMPRENDE LA ADMINISTRACION AL ANIMAL DE UNA CANTIDAD ANTIINFLAMATORIAMENTE EFECTIVO DE FACTOR ANTIINFLAMATORIO. EN UNA CONFORMACION PREFERIDA, EL FACTOR SE AISLA DE LA LECHE PRODUCIDA POR UN ANIMAL PRODUCTOR DE LECHE MANTENIDO EN UN ESTADO HIPERINMUNIZADO.
ES91915601T 1990-09-11 1991-06-12 Factor anti-inflamatorio, metodo de aislamiento y uso. Expired - Lifetime ES2124229T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/580,382 US5242691A (en) 1982-06-03 1990-09-11 Anti-inflammatory factor, method of isolation, and use

Publications (1)

Publication Number Publication Date
ES2124229T3 true ES2124229T3 (es) 1999-02-01

Family

ID=24320860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91915601T Expired - Lifetime ES2124229T3 (es) 1990-09-11 1991-06-12 Factor anti-inflamatorio, metodo de aislamiento y uso.

Country Status (13)

Country Link
US (1) US5242691A (es)
EP (1) EP0548123B1 (es)
JP (1) JPH08502718A (es)
AT (1) ATE171875T1 (es)
AU (1) AU660626B2 (es)
CA (1) CA2090011C (es)
DE (1) DE69130323T2 (es)
DK (1) DK0548123T3 (es)
ES (1) ES2124229T3 (es)
IE (1) IE912109A1 (es)
IL (1) IL98647A (es)
NZ (2) NZ250386A (es)
WO (1) WO1992004035A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650175A (en) * 1982-06-03 1997-07-22 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
CA2086101C (en) * 1990-07-05 2002-11-19 Lee R. Beck Immune suppressive product from milk
US5747296A (en) * 1992-05-11 1998-05-05 Corvas International, Inc. Method of detecting neutophil inhibitory factor mimics
US6090380A (en) * 1994-01-12 2000-07-18 Research Corporation Technologies, Inc. Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin
US5980953A (en) * 1994-10-03 1999-11-09 Stolle Milk Biologics, Inc. Anti-inflammatory factor, method of isolation, and use
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
CA2197515A1 (en) * 1996-07-15 1998-01-16 Reyad Mahmoud Methods of treating milk products
NZ334502A (en) 1996-09-06 2000-11-24 Pall Corp Shear separation method and system for process fluids
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
JP2001342127A (ja) * 2000-06-02 2001-12-11 Nomoto Kikuo 腸吸収性抗炎症因子含有免疫性物質及びその応用
WO2003028668A2 (en) * 2001-10-04 2003-04-10 Protein Therapeutics, Inc. Gammaglobulin treatment of immune disorders
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US20080026983A1 (en) * 2006-07-28 2008-01-31 Gardiner Paul T Compositions and methods for alleviating joint pain and improving joint flexibility
JP2011051914A (ja) * 2009-08-31 2011-03-17 Obihiro Univ Of Agriculture & Veterinary Medicine 低温殺菌処理ホエータンパク濃縮物を含む腸管炎症抑制剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
CH590064A5 (es) * 1973-11-28 1977-07-29 Biokema Sa
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
ATE16349T1 (de) * 1981-04-28 1985-11-15 Stolle Res & Dev Verfahren zur herstellung einer entzuendungshemmenden rindermilch.
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4897265A (en) * 1983-10-27 1990-01-30 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
DE3785033T2 (de) * 1987-07-21 1993-10-07 Stolle Res & Dev Verfahren zum Erhalten von immunregulierenden Faktoren mittels Säugetierimmunisierung.

Also Published As

Publication number Publication date
CA2090011C (en) 2003-12-30
NZ238751A (en) 1994-03-25
JPH08502718A (ja) 1996-03-26
US5242691A (en) 1993-09-07
IE912109A1 (en) 1992-03-11
AU8434091A (en) 1992-03-30
EP0548123A4 (en) 1993-12-08
ATE171875T1 (de) 1998-10-15
WO1992004035A1 (en) 1992-03-19
DK0548123T3 (da) 1999-02-15
IL98647A0 (en) 1992-07-15
EP0548123B1 (en) 1998-10-07
EP0548123A1 (en) 1993-06-30
NZ250386A (en) 1997-06-24
DE69130323D1 (de) 1998-11-12
CA2090011A1 (en) 1992-03-12
DE69130323T2 (de) 1999-05-20
IL98647A (en) 1999-11-30
AU660626B2 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
ES2124229T3 (es) Factor anti-inflamatorio, metodo de aislamiento y uso.
DE3775805D1 (de) Arzneimittel zur behandlung periodontaler erkrankungen.
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DK1142485T3 (da) Fremgangsmåde til forbedring af oplöseligheden af planteproteiner
FI904204A0 (fi) Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter.
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
DK158723C (da) Analogifremgangsmaade til fremstilling af triphenylimidazol-2-yloxyalkansyrer og derivater deraf
FI943625A0 (fi) Menetelmiä tulehduksellisten ihotautien hoitamiseksi
ATE141613T1 (de) Prozess zur darstellung von aspartam aus einem diketopiperazin sowie neue zwischenprodukte und derivate dafür
FR2723095B1 (fr) Procede de preparation de siloxanes cycliques par craquage
DE69207696D1 (de) Einschritt-Verfahren zur Herstellung von Dirithromycin
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE3268024D1 (en) 0-alkyl-0-carbamoyl-glycero-phospho-cholines and process for their preparation
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
IT8123052A0 (it) Procedimento per la preparazione di trattamento di pozzi.
DE69230358T2 (de) Substituiertes N-Fluoropyridiniumsulfonat, Zwischenprodukte und Verfahren zur Herstellung davon
DE68913394D1 (de) Verfahren zur Herstellung von substituierten Phenoxyethylaminen sowie Zwischenverbindungen.
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
FR2510565B1 (fr) Procede de preparation de l'a-(3,4,5-trimethoxybenzoylthio)-propionyl glycine
DE59102006D1 (de) Verfahren zur Isolierung reiner Dinitrotoluole.
NO964631D0 (no) Fremgangsmåte for fremstilling av vesentlig bakteriefritt kolostrum
KR920013611A (ko) 로컬폴리 산화물을 이용한 격리의 제조방법

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 548123

Country of ref document: ES